financetom
Business
financetom
/
Business
/
Progressive Insider Sold Shares Worth $402,612, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Progressive Insider Sold Shares Worth $402,612, According to a Recent SEC Filing
Jan 6, 2025 11:34 AM

02:13 PM EST, 01/06/2025 (MT Newswires) -- John Jo Murphy, Claims President, on January 03, 2025, sold 1,663 shares in Progressive (PGR) for $402,612. Following the Form 4 filing with the SEC, Murphy has control over a total of 60,166 shares of the company, with 45,289 shares held directly and 14,878 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/80661/000112760225000665/xslF345X05/form4.xml

Price: 241.09, Change: -1.13, Percent Change: -0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volkswagen explores stock sale in truckmaker Traton, Bloomberg reports
Volkswagen explores stock sale in truckmaker Traton, Bloomberg reports
May 13, 2024
(Reuters) - Volkswagen is exploring the sale of as much as1 billion euros ($1.08 billion) worth of stock in its heavy truckmaking arm Traton SE ( TRATF ), Bloomberg News reported on Monday, citing people familiar with the matter. The German automaker is talking to potential advisers about the stake sale to institutional investors via an accelerated bookbuilding deal as...
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
May 13, 2024
01:49 PM EDT, 05/13/2024 (MT Newswires) -- Sanara MedTech ( SMTI ) reported Q1 net loss Monday of $0.21 per diluted share, widening from $0.14 a year earlier. One analyst polled by Capital IQ expected a loss of $0.07. Revenue for the quarter ended March 31 was $18.5 million, up from 15.5 million a year earlier. One analyst surveyed by...
Why MiNK Therapeutics Stock Is Up 11% Monday
Why MiNK Therapeutics Stock Is Up 11% Monday
May 13, 2024
MiNK Therapeutics, Inc. ( INKT ) shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million. What Happened: On Monday, MiNK Therapeutics ( INKT ) entered into a stock purchase agreement to sell securities in a private investment in public equity (PIPE) agreement. MiNK said it will sell 4.64 million shares at a price...
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13, 2024
Monday, Takeda Pharmaceutical Company Limited ( TAK ) and AC Immune SA ( ACIU ) announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for Alzheimer’s disease. ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s...
Copyright 2023-2026 - www.financetom.com All Rights Reserved